In the context of the deep integration of life sciences and information technology, the three major fields of biomedicine, precision medicine, and life health are undergoing a paradigm shift from "disease treatment" to "active health". The rapid development of artificial intelligence, big data, and multi omics technologies has made it possible for precision medicine to move from basic research to clinical practice - from gene editing and cell therapy, organoid drug screening, to high-throughput drug discovery based on machine learning, to the closed-loop health management of wearable devices and digital therapies. The innovation chain of the biopharmaceutical industry is being comprehensively reconstructed. At the same time, global population aging and changes in the disease spectrum have raised higher demands on the healthcare system, making interdisciplinary and cross-border collaborative innovation unprecedentedly urgent.
The 2026 International Conference on Biopharmaceuticals, Precision Medicine, and Life Health (BPMLH 2026) aims to build an interdisciplinary and cross-border high-end academic exchange platform, focusing on core issues such as innovative research and development in biomedicine, precision medicine and genomics medicine, life and health management, and digital medicine. It brings together global biomedical scientists, clinical doctors, genomics experts, and scholars and industry representatives in related fields to jointly explore medical innovation paths from molecular to clinical, from treatment to health.

Crosscheck Powered by iThenticate will be used for plagiarism check. The amount of duplication from previously published content should be less than 10%; If the amount of duplication is 10% - 20%, modification maybe required; if the amount of duplication exceeds 20%, the article will be rejected. Please note that there will be no refund for no-shows.

Delegates are encouraged to submit their papers/abstracts to the conference. Good quality papers will be selected by the organizing committee and Prof. Soteris Kalogirou, the editor in chief. After it, the authors will be invited to extent their papers/abstracts and submit them to int_tech@126.com. The normal size of research papers is 4,000-6,000 words excluding abstract and references.
Please kindly specify the subject of your submission as BPMLH 2026 + along with the name of the corresponding author, failing which we regret to inform you that your submission cannot be confirmed.

As a platform for global academic communication, the quality of conference publication has always an aspect attracting much of our attention. To ensure quality of our publication and to better serve the peers in academic circle, we now call for reviewers among professionals and experts of the world.
Professionals and experts who hold PhD (doctoral) degree in the conference related areas are encouraged to join in us and together, we will work hard to become a world-class academic conference.
Please send us your CV by email (int_tech@126.com) if you are interested in it.

Contributors are encouraged to submit papers / abstracts to the conference. The organizing committee will select high-quality papers and recommend them to SCI/SSCI journals. For specific matters, please contact the person in charge of the conferrence.